Loading the security page…
A security analysis is not yet prepared for this market.
Based on the last 12 months of reports, through 30 June 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Foghorn Therapeutics Inc. (FHTX) is a company in the Health care sector; its shares trade on Nasdaq.
The price of Foghorn Therapeutics Inc. (FHTX) on November 10, 2026 is 1.90 $, −7.11 % on the day. Over 52 weeks the stock traded between 1.79 $ and 7.61 $; the price now sits 2 % of the way up that range. Over the past year the price changed by −51.70 %. Market capitalization is 121.83 million $, rank 220 among 380 stocks of the same industry with a known capitalization.
Foghorn Therapeutics Inc. trades on Nasdaq under the ticker FHTX. The company belongs to the Health care sector. The trading history on this page starts on 23 October 2020.
Over the past 52 weeks FHTX has traded between 1.79 $ and 7.61 $. As of 10 November 2026 the price stood 5.84% of the way from the 52-week low to the high.
Over one year FHTX shares fell 51.70%; over six months they fell 54.49%. Volatility over 90 days is 101.95%. Dividends are not included: this is price change only, as of 10 November 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 3.3, below the sector median of 3.7. Calculated from reports for the period ending 30 June 2026.
Foghorn Therapeutics Inc. reported revenue of 37M $ and a net loss of 65M $ over the last four quarters. Net margin is −175.78%. Revenue changed by +51.98% year over year. Earnings per share are −$0.99. Market capitalisation is 122M $.